13FPulse
中
TC

TCRX TSCAN THERAPEUTICS INC

2026Q1 · CUSIP 89854M101 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
59
Δ holders QoQ
-1
Breadth percentile
Top 66%
Whale holders
36
Δ whales
+1
Inst. holding value
$662M
New positions
11
Closed positions
12
Price momentum (1Q)
+2.6%
Put / Call
0/0

Breadth history (34 quarters)

2021Q4: holders=29 2022Q1: holders=25 2022Q2: holders=25 2022Q3: holders=27 2022Q4: holders=29 2023Q1: holders=29 2023Q2: holders=30 2023Q3: holders=33 2023Q4: holders=55 2024Q1: holders=67 2024Q2: holders=81 2024Q3: holders=90 2024Q4: holders=92 2025Q1: holders=93 2025Q2: holders=82 2025Q3: holders=73 2025Q4: holders=60 2026Q1: holders=59 -22 -11 +0 +11 +22 226098 21Q422Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q2 Top 19% -16.0% -63.8%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.96
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+106.7%
Net margin
—
ROE
-128.3%
Debt ratio
52.0%
FCF (TTM)
-$125M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
2023-09-30: EPS -0.24 2024-03-31: EPS -0.32 2024-06-30: EPS -0.28 2024-09-30: EPS -0.25 2024-12-31: EPS -0.29 2025-03-31: EPS -0.26 2025-06-30: EPS -0.28 2025-09-30: EPS -0.28 2025-12-31: EPS -0.18 2026-03-31: EPS -0.22 0M 4M 7M $M -0.35 -0.18 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.